Its products, including the Dexcom G6 and G7, aim to help people with diabetes manage their blood glucose levels through real-time data transmission and monitoring. Shares of the medical device ...

The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

BUT IMAGINE GETTING $1,000 BILLS EVERY MONTH. YEAH, THAT’S THE SHOCKING REALITY FOR SOME PEOPLE WHO THINK THEIR ELECTRIC METERS MIGHT BE TO BLAME. THEY SAY TRYING TO GET A METER REPLACED HAS ...

In March, the FDA cleared Dexcom’s Stelo, making it the first glucose biosensor that doesn’t require a prescription. The small, wearable device, worn on the back of the upper arm, is designed ...

In the first of this six-part series, Mark Andrews puts Xpeng’s G6 sports-utility vehicle through the paces, concluding that it is not so much a car that you drive than the car that drives you.

The XPeng G6 is far more than a Tesla Model Y clone. It’s an existential threat to conventional premium SUVs So swiftly and smoothly does the XPeng G6 park itself after a few taps on the touchscreen, ...

With less than two weeks until the election, a new Emerson College poll shows former President Donald Trump closing in on Vice President Kamala Harris in New Hampshire, where her lead has narrowed ...

An internal leak has revealed the company's projected benchmarks for the upcoming Tensor G5 and G6 chips, which are expected to power the Pixel 10 and Pixel 11 lineups, respectively. In terms of ...

Amid the launch of its first over-the-counter wearable glucose tracker, Dexcom reported that its overall revenues in the U.S. declined year over year despite overall sales coming in slightly ...

Its products include DexCom G4 PLATINUM System, DexCom G5 Mobil, DexCom G6, and DexCom Share. Read More on DXCM: DexCom NewsMORE Related Stocks Indices ...

Its products include DexCom G4 PLATINUM System, DexCom G5 Mobil, DexCom G6, and DexCom Share. Read More on DXCM: DexCom NewsMORE Related Stocks Indices Commodities ...

DexCom (DXCM) reported $994.2 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 2%. EPS of $0.45 for the same period compares to $0.50 a year ago.